Summary
The effects of sotalol after oral administration were measured on the tachycardia induced by strenuous exercise in normal subjects. Plasma sotalol levels were also determined. The oral administration of sotalol (50, 100, 200 and 400 mg) to 6 subjects produced a progressive reduction in the tachycardia induced by severe exercise. This was similar to the effects of 25, 50, 100, 200, 400 and 800 mg given to different subjects. Each increase in sotalol dose produced a successively greater reduction in exercise tachycardia. This did not appear to be maximum even with 800 mg. Oral sotalol was rapidly absorbed and produced peak blood levels in 2 – 3 hours. The plasma levels of sotalol measured 2 hours after the oral administration of 25 to 800 mg showed never more than a six-fold variation between different subjects. The half-life of sotalol in plasma was 12.7 ± SE 1.6 hours. There was a significant correlation between the logarithm of the plasma sotalol concentration and the percentage reduction of exercise heart rate. It is concluded that the oral administration of sotalol either once or twice daily (depending on dose level) will provide satisfactory 24-hour blockade of β-adrenoceptors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bergamaschi, M., Shanks, R.G., Caravaggi, A.M., Mandelli, V.: A comparison of the cardiovascular actions of four adrenergic betareceptor blocking agents in conscious dogs. Amer. Heart J.82 338–351 (1971)
Bodem, G., Chidsey, C.A.: Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man. Clin. Pharmacol. Ther.14 26–29 (1973)
Carruthers, S.G., Kelly, J.G., McDevitt, D.G., Shanks, R.G.: Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate. Clin. Pharmacol. Ther.15 497–509 (1974)
Diamond, L.: Potentiation of bronchomotor responses by beta-adrenergic antagonists. J. Pharmacol. exp. Ther.181 434–445 (1972)
Fitzgerald, J.D., Scales, B.: Effect of a new adrenergic beta-blocking agent (ICI 50172) on heart rate in relation to its blood levels. Int. J. Clin. Pharmacol.16 467–474 (1968)
Frankl, W.S., Soloff, L.A.: Sotalol: A new safe beta-adrenergic receptor blocking agent. Amer. J. Cardiol.22 266–272 (1968)
Garrett, E.R., Schnelle, K.: Separation and spectrofluorometric assay of the beta-adrenergic blocker sotalol from blood and urine. J. pharm. Sci.60 833–839 (1971)
Kofi Ekue, J.M., Lowe, D.C., Shanks, R.G.: Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptive receptors in man. Brit. J. Pharmacol.38 546–553 (1970)
Lish, P.M., Weikel, J.H., Dungan, K.W.: Pharmacological and toxicological properties of two beta-adrenergic receptor antagonists. J. Pharmacol. exp. Ther.149 161–173 (1965)
Lish, P.M., Shelanski, M.V., Labudde, J.A., Williams, W.R.: Inhibition of cardiac chronotropic action of isoproterenol by sotalol (MJ 1999) in rat, dog and man. Curr. ther. Res.9 311–324 (1967)
Schnelle, K., Garrett, E.R.: Pharmacokinetics of the beta-adrenergic blocker sotalol in dogs. J. pharm. Sci.62 362–375 (1973)
Shand, D.G., Nuckolls, E.M., Oates, J.A.: Plasma propranolol levels in adults, with observations in four children. Clin. Pharmacol. Ther.11 112–120 (1970)
Shand, D.G.: Pharmacokinetic properties of the β-adrenergic receptor blocking drugs. Drugs7 39–47 (1974)
Shanks, R.G.: Methods for the evaluation of adrenergic beta-receptor antagonists. In: Methods in drug evaluation (ed. Mantegazza and Piccinni) pp. 183–198. Amsterdam: North Holland Publ. Co. 1966
Somani, P., Fleming, F.G., Chan, G.K., Lum, B.K.B.: Antagonism of epinephrine-induced cardiac arrhytmias by MJ 1999. J. Pharmacol. exp. Ther.151 32–37 (1966)
Stanton, H.C., Kirchgessner, T., Parmenter, K.: Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists. J. Parmacol. exp. Ther.149 174–182 (1965)
Svedmyr, N., Jakobsson, B., Malmberg, R.: Effects of sotalol and propranolol administered orally in man. Europ. J. Pharmacol.8 79–82 (1969)
Svedmyr, N., Malmberg, R., Häggendal, E.: The haemodynamic effects of sotalol (MJ 1999) and propranolol in man. Pharmacol. Clin.2 82–85 (1970)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brown, H.C., Carruthers, S.G., Kelly, J.G. et al. Observations on the efficacy and pharmacokinetics of sotalol after oral administration. Eur J Clin Pharmacol 9, 367–372 (1976). https://doi.org/10.1007/BF00606550
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00606550